Lupus Nephritis
📧 Sign up to get email alerts when something new happens for Lupus Nephritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-07-25FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for mycophenolate mofetil from Hikma Pharmaceuticals USA Inc., resulting in changes to the approved …
-
CLINICAL_TRIALS trial_result · 2012-07-23Clinical Trial Update: Efficacy and Safety of Tripterygium Wilfordii in Patients With Lupus Nephritis [Phase 2, Phase 3]
Clinical trial update on the efficacy and safety of Tripterygium wilfordii for lupus nephritis across Phase 2 and Phase 3 studies. The curre…
-
CLINICAL_TRIALS trial_result · 2012-05-11Clinical Trial Update: Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis [Phase 2, Phase 3]
A Phase 2/3 efficacy and safety study of abatacept for lupus nephritis in systemic lupus erythematosus has been terminated, with results pos…
-
CLINICAL_TRIALS withdrawal · 2012-04-24Clinical Trial Update: Velcade for Proliferative Lupus Nephritis [Phase 4]
A Phase 4 clinical trial evaluating Velcade (bortezomib) for proliferative lupus nephritis was withdrawn.
-
CLINICAL_TRIALS research · 2012-03-06Clinical Trial Update: Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis [Phase 2]
Phase 2 clinical trial studying human umbilical cord-derived mesenchymal stem cells for lupus nephritis; the current status of the study is …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-12-19Clinical Trial Update: Etanercept for the Treatment of Lupus Nephritis [Phase 2]
A Phase 2 trial of etanercept for lupus nephritis was terminated and results have been posted.
-
CLINICAL_TRIALS trial_result · 2011-12-06Clinical Trial Update: A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis. [Phase 3]
A Phase 3 clinical trial evaluating mycophenolate mofetil (CellCept) for lupus nephritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2011-11-03Clinical Trial Update: Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Treatment in Refractory Lupus Nephritis [Phase 3]
A Phase 3 trial evaluated tacrolimus sustained-release capsules as induction therapy in refractory lupus nephritis. The update reports on th…
-
CLINICAL_TRIALS trial_result · 2011-10-14Clinical Trial Update: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis. [Phase 3]
A Phase 3 randomized trial comparing mycophenolate mofetil to azathioprine for maintenance therapy in lupus nephritis has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-29Clinical Trial Update: Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V) [NA]
A completed clinical trial evaluated the combination of tacrolimus (FK506) with mycophenolate mofetil (MMF) in lupus nephritis to assess eff…
-
CLINICAL_TRIALS trial_result · 2011-08-23Clinical Trial Update: Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis [Phase 1]
A Phase 1 trial comparing tacrolimus with cyclophosphamide for lupus nephritis has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-02Clinical Trial Update: Prospective Study of TW in the Treatment of LN Type V With Gross Proteinuria [NA]
A completed prospective study evaluating TW in the treatment of lupus nephritis type V with gross proteinuria.
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: Efficacy and Safety of Tamibarotene(AM80) for Lupus Nephritis [Phase 2]
Reports Phase 2 trial results on the efficacy and safety of Tamibarotene (AM80) for lupus nephritis.
-
CLINICAL_TRIALS trial_result · 2011-06-28Clinical Trial Update: Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare [Phase 2]
Phase 2 trial evaluating the efficacy and safety of enteric-coated mycophenolate sodium in combination with two corticosteroid regimens for …
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: To Compare the Efficacy and Safety of Tripterygium (TW) Versus AZA in the Maintenance Therapy for Lupus Nephritis [NA]
This clinical trial update reports the completion of a study comparing Tripterygium wilfordii (TW) to azathioprine (AZA) as maintenance ther…
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis [NA]
Clinical trial update comparing leflunomide versus azathioprine for maintenance therapy in lupus nephritis; the trial status is currently un…
-
CLINICAL_TRIALS trial_result · 2010-06-23Clinical Trial Update: Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study [Phase 2]
A completed Phase 2 trial comparing Cyclosporine A to intravenous Cyclophosphamide for lupus nephritis in systemic lupus erythematosus.
-
CLINICAL_TRIALS trial_result · 2010-06-03Clinical Trial Update: Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg [Phase 1]
Phase I study in China evaluated the tolerability of a single 30 mg/kg dose of abatacept in lupus nephritis. The results were posted in 2010…
-
CLINICAL_TRIALS trial_result · 2010-05-27Clinical Trial Update: To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN [NA]
A clinical trial comparing FK506 (tacrolimus) with IVC for Class III-IV lupus nephritis has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-23Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV Lupus Nephritis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of rituximab in ISN/RPS 2003 Class III or IV lupus nephritis completed and results were pos…
-
FDA approval · 2010-02-02FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Mycophenolate mofetil submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2009-11-30FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare's generic mycophenolate mofetil. The product is used to prevent organ transpla…
-
CLINICAL_TRIALS trial_result · 2009-10-05Clinical Trial Update: TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL ) [Phase 2, Phase 3]
A Phase 2/3 trial evaluating infliximab (Remicade) for active lupus nephritis (WHO Class V) has been terminated.
-
FDA approval · 2009-09-09FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for mycophenolate mofetil submitted by Hikma Pharmaceuticals USA Inc., updating the labeling for…
-
FDA approval · 2009-06-18FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
The FDA approved Genentech's supplemental application for CellCept (mycophenolate mofetil). The action updates the approved status under a s…